MAPT and Alzheimer disease: Results showed that AD TauO induced tau aggregate formation (molecular mass at ≥ 50 kDa) that was present mostly in the cytosol (Figs. 5, C and D, S6) and modestly enhanced monomeric tau expression in the nuclei (Fig. 5, E and F).